BIOMAT Database Logo BIOMAT Database Logo

Consumer representation on FDA panels. 1978

S H Newman

UI MeSH Term Description Entries
D003256 Community Participation Involvement of members of the community in the affairs of that community. Community Action,Consumer Involvement,Consumer Participation,Community Involvement,Public Participation,Action, Community,Actions, Community,Community Actions,Community Involvements,Consumer Involvements,Involvement, Community,Involvement, Consumer,Involvements, Community,Participation, Community,Participation, Consumer,Participation, Public
D004345 Drug Industry That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. Industries, Pharmaceutic,Industry, Drug,Industry, Pharmaceutic,Industry, Pharmaceutical,Pharmaceutical Industry,Drug Industries,Industries, Drug,Industries, Pharmaceutical,Pharmaceutic Industries,Pharmaceutic Industry,Pharmaceutical Industries
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D014486 United States Food and Drug Administration An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc. Food and Drug Administration (U.S.),USFDA,Food and Drug Administration,United States Food, Drug Administration

Related Publications

S H Newman
FDA relents on consumer science consultants.
March 1973, Science (New York, N.Y.),
S H Newman
Trends in Female Representation on NCCN Guideline Panels.
August 2020, Journal of the National Comprehensive Cancer Network : JNCCN,
S H Newman
FDA advisory panels recommend Lotronex be put back on market.
May 2002, BMJ (Clinical research ed.),
S H Newman
FDA panels probe efficacy of barrier contraceptives.
December 1996, Washington memo,
S H Newman
White House Conference on Consumer Representation Plans.
March 1976, Pennsylvania dental journal,
S H Newman
Regulation: The FDA is overcautious on consumer genomics.
January 2014, Nature,
S H Newman
Standards and consumer representation.
January 1980, Medical instrumentation,
S H Newman
Research and consumer representation.
January 2002, The British journal of general practice : the journal of the Royal College of General Practitioners,
S H Newman
Consumer representation: challenges and pitfalls.
June 2006, Internal medicine journal,
S H Newman
Consumer representation in the NHS.
October 1986, British medical journal (Clinical research ed.),
Copied contents to your clipboard!